Demo Data from EDBT 2026 / reviewers in the wild / expert
Xiaoyan A. Guo
dblp:394/2120
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2022
0000-0003-2210-9122ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 5 heaviest of 5, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › transcriptomics
bulk deconvolution |
0.6 | 1 | 2022 | Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer · Bioinform. 2022 |
Bioinformatics and computational biology
cancer genomics |
0.6 | 1 | 2022 | Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer · Bioinform. 2022 |
Bioinformatics and computational biology › omics data analysis
cell-type deconvolution |
0.6 | 1 | 2022 | Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer · Bioinform. 2022 |
Bioinformatics and computational biology › single-cell analysis › single-cell RNA sequencing
single-cell RNA-seq analysis |
0.6 | 1 | 2022 | Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer · Bioinform. 2022 |
Bioinformatics and computational biology › cancer genomics
tumor heterogeneity |
0.6 | 1 | 2022 | Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer · Bioinform. 2022 |
Methods — techniques the papers use, named apart from their topics
quadratic programming · 0.6
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2022 | Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancerabstractMOTIVATION: Identifying cell types and their abundances and how these evolve during tumor progression is critical to understanding the mechanisms of metastasis and identifying predictors of metastatic potential that can guide the development of new diagnostics or therapeutics. Single-cell RNA sequencing (scRNA-seq) has been especially promising in resolving heterogeneity of expression programs at the single-cell level, but is not always feasible, e.g. for large cohort studies or longitudinal analysis of archived samples. In such cases, clonal subpopulations may still be inferred via genomic deconvolution, but deconvolution methods have limited ability to resolve fine clonal structure and may require reference cell type profiles that are missing or imprecise. Prior methods can eliminate the need for reference profiles but show unstable performance when few bulk samples are available. RESULTS: In this work, we develop a new method using reference scRNA-seq to interpret sample collections for which only bulk RNA-seq is available for some samples, e.g. clonally resolving archived primary tissues using scRNA-seq from metastases. By integrating such information in a Quadratic Programming framework, our method can recover more accurate cell types and corresponding cell type abundances in bulk samples. Application to a breast tumor bone metastases dataset confirms the power of scRNA-seq data to improve cell type inference and quantification in same-patient bulk samples. AVAILABILITY AND IMPLEMENTATION: Source code is available on Github at https://github.com/CMUSchwartzLab/RADs. Haoyun Lei, Xiaoyan A. Guo, Yifeng Tao, Xuecong Fu, Steffi Oesterreich, Adrian V. Lee, Russell Schwartz |
Bioinform. | 2 |